Dylan Lee, MD - Medicare Dermatology in Honolulu, HI

Dylan Lee, MD is a medicare enrolled "Dermatology" physician in Honolulu, Hawaii. His current practice location is 1380 Lusitana St Ste 401, Honolulu, Hawaii. You can reach out to his office (for appointments etc.) via phone at (808) 531-7541.

Dylan Lee is licensed to practice in Hawaii (license number MD-22359) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1174028351.

Contact Information

Dylan Lee, MD
1380 Lusitana St Ste 401,
Honolulu, HI 96813-2440
(808) 531-7541
(808) 531-7542



Physician's Profile

Full NameDylan Lee
GenderMale
SpecialityDermatology
Location1380 Lusitana St Ste 401, Honolulu, Hawaii
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1174028351
  • Provider Enumeration Date: 03/28/2018
  • Last Update Date: 10/04/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0941684849
  • Enrollment ID: I20220825004169

Medical Identifiers

Medical identifiers for Dylan Lee such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174028351NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology MD-22359 (Hawaii)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dylan Lee allows following entities to bill medicare on his behalf.
Entity NameDouglas W Johnson Md Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1528012127
PECOS PAC ID: 7810909686
Enrollment ID: O20060616000044

News Archive

Telbivudine drug prevents perinatal transmission of HBV

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

Advanced Life Sciences Holdings' Restanza promising against tularemia

Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.

Research team explores incisionless procedures for repairing knee and shoulder injuries

Through the use of a newly developed needle arthroscope, incisionless and single-incision surgical procedures are possible for repairing certain types of knee and shoulder injuries suggests a series of Marshall University studies published in Arthroscopy Techniques, a companion to Arthroscopy: The Journal of Arthroscopic and Related Surgery.

Study identifies six risk factors associated with blindness after spine surgery

A study published in the January 2012 issue of Anesthesiology identified six risk factors associated with blindness or partial blindness that can occur after major spine surgery: 1) male sex, 2) obesity, 3) use of a surgical frame that places the head lower than the heart, 4) length of the surgery, 5) amount of blood loss and 6) use of certain fluids that replace lost blood.

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

Read more Medical News

› Verified 7 days ago

Entity NameDylan E Lee Md Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033999362
PECOS PAC ID: 0345690582
Enrollment ID: O20231229001235

News Archive

Telbivudine drug prevents perinatal transmission of HBV

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

Advanced Life Sciences Holdings' Restanza promising against tularemia

Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.

Research team explores incisionless procedures for repairing knee and shoulder injuries

Through the use of a newly developed needle arthroscope, incisionless and single-incision surgical procedures are possible for repairing certain types of knee and shoulder injuries suggests a series of Marshall University studies published in Arthroscopy Techniques, a companion to Arthroscopy: The Journal of Arthroscopic and Related Surgery.

Study identifies six risk factors associated with blindness after spine surgery

A study published in the January 2012 issue of Anesthesiology identified six risk factors associated with blindness or partial blindness that can occur after major spine surgery: 1) male sex, 2) obesity, 3) use of a surgical frame that places the head lower than the heart, 4) length of the surgery, 5) amount of blood loss and 6) use of certain fluids that replace lost blood.

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dylan Lee is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dylan Lee, MD
1380 Lusitana St Ste 401,
Honolulu, HI 96813-2440

Ph: (808) 531-7541
Dylan Lee, MD
1380 Lusitana St Ste 401,
Honolulu, HI 96813-2440

Ph: (808) 531-7541

News Archive

Telbivudine drug prevents perinatal transmission of HBV

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

Advanced Life Sciences Holdings' Restanza promising against tularemia

Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in the study that received 16 mg/kg once-a-day of Restanza (approximate to a human dose of 300 mg) within 24 hours after exposure to a lethal dose of inhaled tularemia survived while only one of the ten animals that received placebo survived.

Research team explores incisionless procedures for repairing knee and shoulder injuries

Through the use of a newly developed needle arthroscope, incisionless and single-incision surgical procedures are possible for repairing certain types of knee and shoulder injuries suggests a series of Marshall University studies published in Arthroscopy Techniques, a companion to Arthroscopy: The Journal of Arthroscopic and Related Surgery.

Study identifies six risk factors associated with blindness after spine surgery

A study published in the January 2012 issue of Anesthesiology identified six risk factors associated with blindness or partial blindness that can occur after major spine surgery: 1) male sex, 2) obesity, 3) use of a surgical frame that places the head lower than the heart, 4) length of the surgery, 5) amount of blood loss and 6) use of certain fluids that replace lost blood.

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

Read more News

› Verified 7 days ago


Dermatology Doctors in Honolulu, HI

Dr. Jay L. Grekin, M.D.
Dermatology
Medicare: Medicare Enrolled
Practice Location: 888 S King St, Honolulu, HI 96813
Phone: 808-522-4360    Fax: 808-522-3361
Bradley S. Lau, MD
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819
Phone: 808-432-0000    
Dr. Geoffrey Strider Farnsworth, M.D.
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 1 Jarrett White Rd, Honolulu, HI 96819
Phone: 808-433-6661    
Dr. Linda E. Fancher, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1010 S King St Ste 220, Honolulu, HI 96814
Phone: 808-597-8038    Fax: 808-596-2387
Janice Matsunaga, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1329 Lusitana St, Suite 507, Honolulu, HI 96813
Phone: 808-532-0155    Fax: 808-532-0160
Dr. Iris Kimhayoung Noh, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 888 S King St, Honolulu, HI 96813
Phone: 808-522-4360    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.